Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes

Journal of Experimental Medicine

Volumn 184, Issue 1, 1996, Pages 121-130

  Blake, James ^a   Johnston, Janet V ^a   Hellström, Karl Erik ^a   Marquardt, Hans ^a   Chen, Lieping ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; ASCITES TUMOR; CANCER; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; FEMALE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPE MAPPING; FEMALE; H-2 ANTIGENS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030018874     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.1.121     Document Type: Article

References (41)

1. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7: 601-624.
2. Yewdell, J.W., and J.R. Berinink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1-123.
3. Heemels, M.T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463-491.
4. Rammensee, H.-G., K. Falk, and O. Rotzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11:213-244.
5. Engelhard, V.H. 1994. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 12: 181-207.
6. Chien, Y.H., and M.M. Davis. 1993. How alpha beta T-cell receptors 'see' peptide/MHC complexes. Immunol. Today. 14:597-602.
7. Ruppert, J.,J. Sidney, E. Celis, R.T. Kubo, H.M. Grey, and A. Sette. 1995. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell. 74:929-937.
8. Udaka, K., K.-H. Wiesmüller, S. Kienle, G. Jung, and P. Walden. 1995. Decrypting the structure ot major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J. Exp. Med. 181: 2097-2108.
9. Houbiers, J.G.A.. H.W. Nijman, S.H. van der Burg, J.W. Drijfhout, P. Keneman, C.J.H. van de Velde, A. Brand, F. Momburg, W.M. Kast, and C.J.M. Melief. 1993. In vitro induction of human cytotoxic T lymphocyte response against peptides of mutant and wild-type p53. Eur. J. Immunol. 23: 2072-2077.
10. Bellone, M., G. Iezzi, A.A. Manfredi, M.P. Protti, P. Dellabona, G. Casorati, and C. Rugarli. 1994. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells. Eur. J. Immunol. 24:2691-2698.
11. Peace, D.J., J.W. Smith, W. Chen, S.G. You, W.L. Cosand, J. Blake, and M.A. Cheever. 1994. Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide. J. Exp. Med. 179:473-479.
12. Feltkamp, M., H.L. Smits, M. Vierboom, R.P. Minnaar, B.M. deJough, J.W. Drijfhout, J. Schegget, C.J.M. Melief, and W.M. Kast. 1993. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur.J. Immunol. 23:2242-2249.
13. Celis, E., V. Tsai, C. Crimi, R. DeMars, P.A. Wentworth, R.W. Chesnut, H.M. Grey, A. Steet, and H.M. Serra. 1994. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and syngeneic peptide epitopes. Proc. Natl. Acad. Sci. USA. 91:2105-2109.
14. Mandelboim, O., G. Berke, M. Fridkin, M. Feldman, M. Eisenstein, and L. Eisenbach. 1994. CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature (Lond.). 369:67-61.
15. Mandelboim, O., E. Vadai, M. Fridkin, A. Katz-Hillel, M. Feldman, G. Berke, and L. Eisenbach. 1995. Regression of established murine carcinoma metastases following vaccination with tumor-associated antigen. Nature Med. 1:1179-1183.
16. Kast, W.M., L. Roux, J. Curren, H.J.J. Blom, A.C. Wourdouw, R.H. Meloen, D. Kolakofsky, and C.J.M. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA. 88:2283-2287.
17. Rothbard, J.B., and M.L. defter. 1990. Interactions between immunogenic peptides and MHC proteins. Annu. Rev. Immunol. 9:527-566.
18. Treversari, C., P. van der Bruggen, I.F. Luescher, C. Lurquin, P. Chomez, A. Van Pel, E. de Plaen, A. Amar-Costesec, and T. Boon. 1992. A nonapeptide encoded by human MAGE-1 is recognized on HLA-A1 by cytotoxic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176: 1453-1457.
19. Kast, W.M., R.M.P. Brandt, J. Sidney, J.W. Drijfhout, R.T. Kubo, C.J.M. Melief, and A. Sette. 1994. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152: 3904-3912.
20. Uenaka, K., T, Ono, T. Akisawa, H. Wada, T. Yasuda, and E. Nakayama. 1994. Identification of a unique antigen peptide pRL1 on BALB/c RL 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene. J. Exp. Med. 180:1599-1607.
21. Slingluff, Jr., C.L., D.F. Hunt, and V.H. Engelhard. 1994. Direct analysis of tumor-associated peptide antigens. Curr. Opin. Immunol. 6:733-740.
22. Boon, T., J.-C. Cerottini, B. Van den Eynde, P. Van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337-365.
23. Gavin, M.A., B. Dere, A.G. Grandea, III, K.A. Hogquist, and M.J. Bevan. 1994. Major histocompatibility complex class I allele-specific peptide libraries: identification of peptides that mimic an H-Y T cell epitope. Eur. J. Immunol. 24: 2124-2133.
24. Schumacher, T.N., M.G.M. Van Bleek. M.-T. Heemels, K. Deres, K.W. Li, M. Imarai, L.N. Vernie, S.G. Nathenson, and H.L. Ploegh. 1992. Synthetic peptide libraries in the determination of T cell epitopes and peptide binding specificity of class I molecules. Eur. J. Immunol. 22:1405-1412.
25. Chen, L., P McGowan, S. Ashe, J. Johnston, Y. Li, I. Hellström, and K.E. Hellström. 1994. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179:523-532.
26. + cytolytic T lymphocytes. J. Exp. Med. 183:791-800.
27. Ljunggren, H.-G., and K. Kärre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants: analysis of the mechanism. J. Exp. Med. 162:1745-1752.
28. Gausepohl, H., C. Boulins, W. Kraft, and R.W. Frank. 1992. Automated multiple peptide synthesis. Peptide Res. 5:315-320.
29. Blake, J., and L. Litzi-Davis. 1992. Evaluation of peptide libraries: an iterative strategy to analyze the reactivity of peptide mixtures with antibodies. Bioconjugate Chem. 3:510-513.
30. Alexander, J., J. Sidney, S. Southwood, J. Ruppert, C. Oseroff, A. Maewal, K. Snoke, H.M. Serra, R.T. Kubo, A. Sette, and H.M. Grey. 1994. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity. 1:751-761.
31. Marth, J.D., R. Peet, E.G. Krebs, and R.M. Perlmutter. 1985. A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell. 43:393-404.
32. Yang, G., K.E. Hellström, M.T. Mizuno, and L. Chen. 1995. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation. J. Immunol. 155:3897-3903.
33. Li, Y., K.E. Hellström, S.A. Newby, and L. Chen. 1996. Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors. J. Exp. Med. 183:639-644.
34. Valmori, D., J.F. Romero, J.L. Maryanski, P. Romero, and G. Corradin. 1994. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. Eur. J. Immunol. 24:1458-1462.
35. Sadovnikova, E., X. Zhu, S.M. Collins, J. Zhou, K. Vousden, L. Crawford, P. Beverley, and H.J. Stauss. 1994. Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papillomavirus E7 protein. Int. Immunol. 6:289-296.
36. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W.M. Kast, C.J.M. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586-5592.
37. Lethe, B., B. Van den Eynde, A. Van Pel, G. Corradin, and T. Boon. 1992. Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide. Eur. J. Immunol. 22:2283-2288.
38. + cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tumor- or helper peptides in priming for skin test reactivity to a P815AB-related peptide. Eur. J. Immunol. 25:2797-2802.
39. Chen, L., S. Ashe, W.A. Brady, I. Hellström, K.E. Hellström, J.A. Ledbetter. P. McGowan, and P.S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71:1093-1102.
40. + T cells by B7-transfected melanoma cells. Science (Wash. DC). 259:368-370.
41. Young, J.W., and K. Inaba. 1996. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity (Commentary). J. Exp. Med. 183:7-11.